PIP Antikörper (Biotin)
Kurzübersicht für PIP Antikörper (Biotin) (ABIN1396422)
Target
Alle PIP Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Homologie
- Rat
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from rat GCDFP15
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:100-1000
IHC-P 1:100-500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C for 12 months.
-
Haltbarkeit
- 12 months
-
-
- PIP (Prolactin-Induced Protein (PIP))
-
Andere Bezeichnung
- Gcdfp15
-
Hintergrund
-
Synonyms: GCDGP 15, GCDGP-15, Gp17, GPIP4, Gross cystic disease fluid protein 15, Prolactin induced protein, Prolactin inducible protein precursor, SABP, Secretory actin binding protein.
Background: Gross cystic disease is a common premenopausal disorder in which gross cysts are the predominant pathologic lesion. It is characterized by production of a fluid secretion which accumulates in the breast cysts. Gross cystic disease fluid is a pathologic secretion from breast composed of several glycoproteins, including a unique 15 kDa monomer protein, GCDFP 15. The cells within the body that produce GCDFP 15 appear to be restricted primarily to those with apocrine function. Studies have found GCDFP 15 to be a highly specific and sensitive marker for breast cancer.
Target
-